Analysis Of Vaccination Campaign Against Hpv And The Perspective Of Vaccinated Population
The Ministry of Health has provided for the girls population aged nine to 13 years, the quadrivalent vaccine against Human Papillomavirus as a preventive measure for cancer of the cervix, with the initial proposal to achieve 80% of this population.
To analyze the vaccine coverage and the perspective of the target population about the vaccine against the Human Papillomavirus.
This was a quantitative and qualitative field research in descriptive character, conducted through the Information System of the National Program for Immunization and with a sample of 86 adolescents in the city of São José do Egito/PE/BR.
The vaccination coverage showed a reduction in sequence of the vaccination schedules of 19,53% in the first phase of the campaign and of 24.07% in the second phase. It was also noted that lack accurate information for more than 50% of respondents, 15.11% had local and / or systemic reactions and 89,53% of them expect positive results with the vaccine against the Human Papillomavirus.
The results showed a discontinuity in the prophylaxis scheme, but for the teenagers who took the vaccine there is confidence that the immunobiological has the desired effect, protecting them against viruses and future cancer of the cervix.
Keywords: Health services; Vaccine; Adolescents; Human Papillomavirus.
2. Domingues CMAS, TeixeiraAMS. Vaccination coverage and immunopreventable diseases in Brazil in the period 1982-2012: Progress and Challenges of the National Immunization Program. Epidemiol. Serv. Health, Brasilia. 2013; January to March, 22 (1): 9-27.
3. DominguesCMAS, Woycicki JR, Rezende KS, Henriques CMP. National Immunization Program: the introduction policy of new vaccines. Rev. Electronic Management & Health in 2015.; 6 (4): 3250-3274.
4. Zardo GP, Farah FP, Mendes FG, Franco CAGS, Molina GVM, Melo GN, et al. Vaccine as immunizing agent against HPV. Science & Public Health. 2014; 19 (9): 3799-3808.
5. Ministry of Health. Secretariat of Health Surveillance. Department of Epidemiological Surveillance. National Immunization Program (NIP): 40. - Brasilia: (DF) .2013a.
6. Coelho PLS, Calestini GLS, Alvo FS, Freitas JMM, Castro PMV, Konstantyner T. Safety of human papillomavirus vaccine 6, 11, 16 and 18 (Recombinant): systematic review and meta-analysis. Rev. Paul. Pediatr.2015; 33 (4): 474-482.
7. Giuliano AR, Palefsky JM, Goldstone S, Moreira Junior ED, Penny ME, Aranda C, et al.Efficacy of quadrivalent HPV Vaccine against HPV Infection and Disease in Males. N. Engl. 2011 J. Med.; 364: 401-411. Available at:
8. Inca. HPV and cancer. 2014. Available at:
9. BorsattoAZ, Vidal MLB, Rocha RCNP. HPV vaccine and the Prevention of Cervical Cancer: subsidies for practice. Journal of Oncology. 2011; 57 (1): 67-74.
10. Ministry of Health. Secretary of Health Surveillance. Department of Communicable Disease Surveillance. General Coordination The National Immunization Program. Technical Information About Papillomavirus Vaccine human use6, 11, 16 and 18 (Recombinant). - Brasilia: (DF). 2014b.
11. Ministry of Health. Secretary of Health Surveillance. Department of Epidemiological Surveillance. Cold chain Manual. - 4. ed. - Brasilia DF). 2013c.
12. Brazilian Institute of Geography and Statistics. Cities. Pernambuco. São José do Egito. 2015. Available at:
13. Brazil. National Health Council. Resolution no. 466 of December 12, 2012. This research and testing in humans. Brasilia: Official Gazette 2012.
14. Osis MJD, Duarte GA, SousaMH. Knowledge and PHS users attitude about HPV and the vaccines available in Brazil. Rev. Public Health. 2014; 48 (1): 123-133.
15. Ministry of Health. Secretary of Health Surveillance. Department of Communicable Disease Surveillance. General Coordination The National Immunization Program. Practical guide to HPV: Questions and Answers. - Brasilia: Ministry of Health, 2013b.
16. Gonçalves MB, Miranda VI, Soares VM, Galieta T. conversations on health, sexually transmitted diseases and vaccines. In: V Enebio and II Erebio Regional 1, 2014. Magazine SBEnBio, n.7, out, in 2014.
17. Barreira AM, Oliveira VA, Machado VMP, Brenna SMF. Vaccine for Human Papillomavirus. Science in Health. 2010; Jan-ABR1 (1): 83-87.
18. Brazilian Bulletin of Health Technology Assessment cervical cancer:. A vaccine to prevent HPV and the challenge to improve the tracking of quality in Brazil. ISNN 1983-7003. Year VI, No. 17, December, 2011.
19. Araújo SCF, Caetano R, Braga JU, Silva CVF. Effectiveness of commercially available vaccines against papillomavirus infection in women: a systematic review and meta-analysis. Cad. Saúde Pública, Rio de Janeiro. 2013; 29 (Supp: S32-S44).
20. J Binda, Bianco MF Sousa MS. The work of community health workers in evidence: an analysis focusing on activity. Health Soc., São Paulo. 2013; 22 (2): 389-402.
21. Markowitz LE, S Hariri, Lin C, Dunne EF, Steinau M, McQuillan G, et al. Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J. Infect. Dis. 2013; 208 (3): 385-393. Available at:
22. Nunes CBL, Arruda KM, TN Pereira. Presentation of the effectiveness of HPV vaccine distributed by SUS from 2014 based on studies Future I, Future II and Villa et al. Acta BiomedicaBrasiliensia. 2015; July 6 (1): 1-9.
Copyright policies & self-archiving
We are a RoMEO green journal.
Author's Pre-print: author can archive pre-print (ie pre-refereeing)
Author's Post-print: author can archive post-print (ie final draft post-refereeing)
Publisher's Version/PDF: author can archive publisher's version/PDF
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access and Benefits of Publishing Open Access).
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.
Articles are published Under License of Creative Commons Attribution 4.0 License ©